产品名称：Anti-IGBP1/FITC抗体

Anti-IGBP1/FITC抗体

产品编号YB0298R-FITC

英文名称Anti-IGBP1/FITC

中文名称FITC标记的**球蛋白结合蛋白-1抗体

别    名Alpha 4; B cell signal transduction molecule alpha 4; B-cell signal transduction molecule alpha 4; bA351K23.1; CD79a binding protein 1; CD79a-binding protein 1; IBP 1; IBP1; IGBP 1; Igbp1; IGBP1_HUMAN; Immunoglobulin (CD79A) binding protein 1; Immunoglobulin binding protein 1; Immunoglobulin-binding protein 1; Protein alpha 4; Protein alpha-4; Protein phosphatase 2A regulatory subunit alpha 4; Renal carcinoma antigen NY REN 16; Renal carcinoma antigen NY-REN-16.  

Anti-IGBP1/FITC抗体

说 明 书100ul  

研究领域肿瘤  细胞生物  **学  神经生物学  信号转导  激酶和磷酸酶  

抗体来源Rabbit

克隆类型Polyclonal

交叉反应 Human, Mouse, Rat, Pig, Cow, Guinea Pig,

产品应用Flow-Cyt=1:50-200 IF=1:50-200  

not yet tested in other applications.

optimal dilutions/concentrations should be determined by the end user.

分 子 量44kDa

Anti-IGBP1/FITC抗体性    状Lyophilized or Liquid

浓    度1mg/ml

免 疫 原KLH conjugated synthetic peptide derived from human Immunoglobulin binding protein 1

亚    型IgG

纯化方法affinity purified by Protein A

储 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

保存条件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

Anti-IGBP1/FITC抗体

产品介绍background:

The proliferation and differentiation of B cells is dependent upon a B-cell antigen receptor (BCR) complex. Binding of antigens to specific B-cell receptors results in a tyrosine phosphorylation reaction through the BCR complex and leads to multiple signal transduction pathways. [provided by RefSeq, Jul 2008].

Function:

Associated to surface IgM-receptor; may be involved in signal transduction. Involved in regulation of the catalytic activity of PP2A, PP4 and PP6 phosphatases catalytic subunits by protecting them from degradative polyubiquitination until they associate with regulatory subunits.

Subunit:

Associates with PP2A-alpha and PP2A-beta catalytic subunits, and with PP4 and PP6. Interacts with MID1 and MID2. Interacts with Ubiquitin.

Subcellular Location:

Cytoplasm (Potential).

Tissue Specificity:

Ubiquitously expressed with highest levels in heart, skeletal muscle and pancreas.

Post-translational modifications:

Phosphorylated.

Monoubiquitination by MID1 triggers calpain-mediated cleavage and switches IGBP1 activity from protective to destructive.

DISEASE:

Mental retardation, X-linked, syndromic, 28 (MRXS28) [MIM:300472]: A mental retardation syndrome characterized by agenesis of the corpus callosum, coloboma of the iris and optic nerve,Anti-IGBP1/FITC抗体 severe retrognathia, and intellectual deficit. Mental retardation is defined by significantly below average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. Note=The disease is caused by mutations affecting the gene represented in this entry.

Similarity:

Belongs to the IGBP1/TAP42 family.

Contains 1 UIM (ubiquitin-interacting motif) repeat.

Database links:

Entrez Gene: 3476 Human

Entrez Gene: 18518 Mouse

Entrez Gene: 58845 Rat

Omim: 300139 Human

SwissProt: P78318 Human

SwissProt: Q61249 Mouse

SwissProt: O08836 Rat

Unigene: 496267 Human

Unigene: 7454 Mouse

Unigene: 7079 Rat

Important Note:

This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

CD79a表达于从前B细胞到浆细胞的整个B细胞发育阶段。

CD79a与CD79b构成B细胞受体复合体，在介导IgM从细胞内转到细胞膜上起重要作用。CD79a是B细胞常用标记物。CD79复合物是异二聚体分子，由CD79a/mb-1和CD79b/B29 组成。在B细胞表面非共价地与膜结合的**球蛋白相连，构成B细胞抗原受体。在大多数前B细胞急性**细胞白血病、B细胞系、B细胞**瘤和和某些骨髓瘤中发现有CD79a的存在。主要用于B**细胞的判断和B细胞**瘤的诊断。